NZ600453A - Inhibitors of akt activity - Google Patents

Inhibitors of akt activity

Info

Publication number
NZ600453A
NZ600453A NZ600453A NZ60045310A NZ600453A NZ 600453 A NZ600453 A NZ 600453A NZ 600453 A NZ600453 A NZ 600453A NZ 60045310 A NZ60045310 A NZ 60045310A NZ 600453 A NZ600453 A NZ 600453A
Authority
NZ
New Zealand
Prior art keywords
inhibitors
akt activity
formula
pharmaceutical compositions
serine
Prior art date
Application number
NZ600453A
Other languages
English (en)
Inventor
Lixin Zhang
Graham Peter Trevitt
Hugues Miel
Frank Burkamp
Timothy Harrison
Andrew John Wilkinson
Charles-Henry Fabritius
Original Assignee
Almac Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almac Discovery Ltd filed Critical Almac Discovery Ltd
Publication of NZ600453A publication Critical patent/NZ600453A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NZ600453A 2009-12-23 2010-12-23 Inhibitors of akt activity NZ600453A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0922589.7A GB0922589D0 (en) 2009-12-23 2009-12-23 Pharmaceutical compounds
PCT/GB2010/002329 WO2011077098A1 (en) 2009-12-23 2010-12-23 Inhibitors of akt activity

Publications (1)

Publication Number Publication Date
NZ600453A true NZ600453A (en) 2013-10-25

Family

ID=41716932

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ600453A NZ600453A (en) 2009-12-23 2010-12-23 Inhibitors of akt activity

Country Status (22)

Country Link
US (1) US9221838B2 (el)
EP (1) EP2516435B8 (el)
JP (1) JP5923043B2 (el)
KR (1) KR20140015157A (el)
CN (1) CN102791708B (el)
AU (1) AU2010334591C1 (el)
BR (1) BR112012015677A2 (el)
CA (1) CA2783340C (el)
CY (1) CY1115686T1 (el)
DK (1) DK2516435T3 (el)
ES (1) ES2503794T3 (el)
GB (1) GB0922589D0 (el)
HK (1) HK1171013A1 (el)
IL (1) IL220153A (el)
MX (1) MX2012007274A (el)
NZ (1) NZ600453A (el)
PL (1) PL2516435T3 (el)
PT (1) PT2516435E (el)
RU (1) RU2579513C2 (el)
SG (1) SG181517A1 (el)
SI (1) SI2516435T1 (el)
WO (1) WO2011077098A1 (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201205164D0 (en) * 2012-03-23 2012-05-09 Almac Discovery Ltd Pharmaceutical compounds
US10336702B2 (en) * 2014-12-23 2019-07-02 Bergenbio Asa Pharmaceutically active compounds
CN111943962A (zh) * 2015-02-27 2020-11-17 大鹏药品工业株式会社 咪唑并噁嗪晶体、含有所述晶体的药物组合物和制备所述晶体的方法
GB201603779D0 (en) 2016-03-04 2016-04-20 Mission Therapeutics Ltd Novel compounds
EP3493818A4 (en) * 2016-08-07 2020-04-29 The Wistar Institute Of Anatomy And Biology METHODS FOR DETECTION AND TREATMENT OF A PT346 PDK1 EXPRESSING TUMOR
SG11201912397RA (en) * 2017-06-22 2020-01-30 Curadev Pharma Ltd Small molecule modulators of human sting
AU2018329840A1 (en) 2017-09-07 2020-03-19 Augusta University Research Institute, Inc. Specific Akt3 activator and uses thereof
GB2600384A (en) * 2020-09-30 2022-05-04 Vaderis Therapeutics Ag Allosteric AKT inhibitors for use in the treatment of hereditary hemorrhagic telangiectasia

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD1861G2 (ro) * 1994-11-14 2002-09-30 Уорнер-Ламберт Кампэни Derivaţi ai 6-arilpirido[2,3-d]pirimidinelor şi naftiridinelor, compoziţie farmaceutică pe baza lor, metode de tratament şi de inhibare a proliferării şi migraţiei celulei receptorului tirozinkinazei
TWI301760B (en) * 2004-02-27 2008-10-11 Merz Pharma Gmbh & Co Kgaa Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
CN101242834A (zh) * 2004-12-15 2008-08-13 默克公司 Akt活性抑制剂
MX2007015578A (es) * 2005-06-10 2008-03-06 Merck & Co Inc Inhibidores de la actividad akt.
WO2008011032A1 (en) * 2006-07-17 2008-01-24 Amgen Inc. Quinazoline and pyridopyrimidine derivatives as p38 kinase inhibitors
EP2120951A4 (en) 2006-12-06 2012-02-15 Merck Sharp & Dohme INHIBITORS OF AKT ACTIVITY
AR064010A1 (es) 2006-12-06 2009-03-04 Merck & Co Inc Inhibidores de la actividad de la akt
US7999107B2 (en) * 2007-01-31 2011-08-16 Merck Sharp & Dohme Corp. Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulators
EP2299825B1 (en) 2008-06-03 2013-07-31 Merck Sharp & Dohme Corp. Inhibitors of akt activity
US8207169B2 (en) * 2008-06-03 2012-06-26 Msd K.K. Substituted [1,2,4]triazolo[4′,3′:1,6]pyrido[2,3-b]pyrazines of the formula D

Also Published As

Publication number Publication date
EP2516435B8 (en) 2014-10-15
HK1171013A1 (en) 2013-03-15
AU2010334591B2 (en) 2014-04-10
US9221838B2 (en) 2015-12-29
PL2516435T3 (pl) 2015-01-30
GB0922589D0 (en) 2010-02-10
RU2012131115A (ru) 2014-01-27
SI2516435T1 (sl) 2014-12-31
PT2516435E (pt) 2014-11-13
ES2503794T3 (es) 2014-10-07
BR112012015677A2 (pt) 2015-06-30
JP5923043B2 (ja) 2016-05-24
CA2783340C (en) 2015-11-24
CA2783340A1 (en) 2011-06-30
RU2579513C2 (ru) 2016-04-10
CY1115686T1 (el) 2017-01-25
US20130116243A1 (en) 2013-05-09
IL220153A0 (en) 2012-07-31
EP2516435A1 (en) 2012-10-31
SG181517A1 (en) 2012-07-30
EP2516435B1 (en) 2014-08-06
IL220153A (en) 2015-05-31
WO2011077098A9 (en) 2012-04-19
WO2011077098A1 (en) 2011-06-30
JP2013515710A (ja) 2013-05-09
KR20140015157A (ko) 2014-02-06
CN102791708B (zh) 2016-03-02
MX2012007274A (es) 2012-10-03
DK2516435T3 (da) 2014-10-13
CN102791708A (zh) 2012-11-21
AU2010334591A1 (en) 2012-06-21
AU2010334591C1 (en) 2014-07-31

Similar Documents

Publication Publication Date Title
WO2011033265A8 (en) Pharmaceutical compounds
MX2011009796A (es) Inhibidores de la cinasa pi3.
MX340402B (es) Inhibidores triciclicos de cinasas.
NZ600453A (en) Inhibitors of akt activity
MX2011011335A (es) Inhibidores de fosfoinositida 3 cinasa y/u objetivo mamifero de rapamicina.
JO2998B1 (ar) مشتقات بيبيريدينون كمثبطات mdm2 لعلاج السرطان
MX2012000711A (es) Inhibidores de pirrolopirazina de cinasas.
MX2012000709A (es) Inhibidores de pirrolopiridina de cinasas.
GEP20146146B (en) Pyrrolopyrimidine compounds as inhibitors of cdk4/6
TN2012000578A1 (en) Tetrahydro-pyrido-pyrimidine derivatives
WO2010008847A3 (en) Pi3k/m tor inhibitors
MX352672B (es) Compuestos heterocíclicos como inhibidores de mdm2 para el tratamiento del cáncer.
MX2012013197A (es) Inhibidores de indazol de cinasa.
TN2014000016A1 (en) 4 - piperidinyl compounds for use as tankyrase inhibitors
UA111161C2 (uk) Похідна фталазинонкетону, спосіб її одержання та її фармацевтичне застосування
MY164776A (en) Heterocyclic compound
MX2011005934A (es) Compuestos organicos.
MY172924A (en) Neprilysin inhibitors
PH12015500211B1 (en) 4-methyl-2,3,5,9,9b-pentaaza-cyclopenta[a]naphthalenes
IN2012DN02139A (el)
MX2012004780A (es) Inhibidores de akt.
WO2010150211A3 (en) Use of derivatives of indoles for the treatment of cancer
MX360330B (es) Regimen de administracion para nitrocatecoles.
IN2012DN03846A (el)
MX2009003793A (es) Inhibidores de cinasa.

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 23 DEC 2015 BY LEA

Effective date: 20141203

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 23 DEC 2016 BY LEA SKYLLERSTEDT

Effective date: 20151210

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 23 DEC 2017 BY CPA GLOBAL (PATRAFEE)

Effective date: 20161208

LAPS Patent lapsed